Primary Care Clinics in Pacific, MO Accepting Medicare
3 Primary Care Clinics found. Showing 1 - 3
 Your Optimal Healthcare Llc Clinic/Center - Primary Care Medicare: Medicare Enrolled Practice Location: 409 W Osage St, Pacific, MO 63069 Phone: 636-200-8555 Fax: 636-200-8560 |
Patients First Health Care Llc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 307 Noonan Dr, Pacific, MO 63069 Phone: 636-271-9700 Fax: 636-257-6016 |
Pacific Medcare Center Family Medicine Medicare: Medicare Enrolled Practice Location: 319 N 1st St, Pacific, MO 63069 Phone: 636-271-3500 Fax: 636-271-9955 |
News Archive
Congressional appropriations decisions will affect women's health worldwide
"[E]vidence shows that family planning prevents the needless deaths of women worldwide," which should "be cause to sustain or even increase U.S. investments in these programs," Chloe Cooney, director of global advocacy for the Planned Parenthood Federation of America (PPFA), writes in this RH Reality Check blog post.
Vical presents Phase 2 trial results of TransVax CMV vaccine at World Vaccine Congress
Vical Incorporated announced today that the company's TransVax cytomegalovirus vaccine elicited sustained increases in both cellular and antibody immune responses compared with placebo through the final 12-month follow-up in an ongoing Phase 2 trial in hematopoietic cell transplant recipients.
Third-quarter fiscal 2009 results announced by Digirad
Digirad Corporation today reported the Company continued to generate positive cash flow, improved gross margins in its DIS (Digirad Imaging Solutions) business, and maintained its total cash and investments position of more than $31 million in its third quarter ended September 30, 2009, staying on track to record positive net earnings for the year, despite lower camera sales in its product segment.
ARCA biopharma to receive US patent for methods of heart failure treatment with genetic testing based bucindolol
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular diseases, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its U.S. Patent Application Number 11/226,908 entitled "Methods for Treatment with Bucindolol Based on Genetic Targeting." The Notice of Allowance is the USPTO's official communication that the examination of the patent application has been successfully completed and that a patent will be issued.
› Verified 1 days ago